“A Prospective Observational Analysis of Endometrial Cancer Risk Associated with Thyroid Hormone Dysregulation: Research Article” (2024) Journal of Pharma Insights and Research, 2(3), pp. 195–201. doi:10.69613/mrrz3y47.